US Drug Recall Register
Class II · Moderate risk Terminated Initiated Aug 23, 2021 (5 years ago)

Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications

What was recalled

Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01

Recalling firm
Viatris
NDC code
0071-1029-01
Origin
WV, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0851-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Pregabalin recalls

See all